Company Filing History:
Years Active: 2001-2004
Title: Innovations of James Christopher Stephen Clegg
Introduction
James Christopher Stephen Clegg is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for DNA encapsulation. With a total of 3 patents to his name, Clegg's work focuses on advancing vaccination and gene therapy techniques.
Latest Patents
Clegg's latest patents include a method of making microencapsulated DNA for vaccination and gene therapy. This innovative method describes the creation of a microparticle that contains DNA coding for a polypeptide, utilizing a solvent extraction method at elevated temperatures. The oral administration of this microparticle leads to its expression, which is crucial for stimulating antibody formation in recipients. Additionally, the DNA coding for a non-immunogenic polypeptide is intended for gene therapy applications. Importantly, the DNA is incorporated into the microparticle without any destruction of its function, ensuring its efficacy.
Career Highlights
Throughout his career, Clegg has worked with reputable organizations such as the Microbiological Research Authority and the Health Protection Agency. His experience in these institutions has allowed him to refine his expertise in microbiology and biotechnology, contributing to his innovative patent developments.
Collaborations
Clegg has collaborated with notable colleagues, including David Hugh Jones and Graham Henry Farrar. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
James Christopher Stephen Clegg's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work in microencapsulated DNA for vaccination and gene therapy represents a promising advancement in medical science.